Your browser doesn't support javascript.
loading
Oral health, dental care and mouthwash associated with upper aerodigestive tract cancer risk in Europe: the ARCAGE study.
Ahrens, Wolfgang; Pohlabeln, Hermann; Foraita, Ronja; Nelis, Mari; Lagiou, Pagona; Lagiou, Areti; Bouchardy, Christine; Slamova, Alena; Schejbalova, Miriam; Merletti, Franco; Richiardi, Lorenzo; Kjaerheim, Kristina; Agudo, Antonio; Castellsague, Xavier; Macfarlane, Tatiana V; Macfarlane, Gary J; Lee, Yuan-Chin Amy; Talamini, Renato; Barzan, Luigi; Canova, Cristina; Simonato, Lorenzo; Thomson, Peter; McKinney, Patricia A; McMahon, Alex D; Znaor, Ariana; Healy, Claire M; McCartan, Bernad E; Metspalu, Andres; Marron, Manuela; Hashibe, Mia; Conway, David I; Brennan, Paul.
Afiliación
  • Ahrens W; Department of Epidemiological Methods and Etiologic Research, Leibniz Institute for Prevention Research and Epidemiology - BIPS, Bremen, Germany; Institute for Statistics, Faculty of Mathematics and Computer Science, University of Bremen, Bremen, Germany. Electronic address: ahrens@bips.uni-bremen.d
  • Pohlabeln H; Department of Biometry and Data Management, Leibniz Institute for Prevention Research and Epidemiology - BIPS, Bremen, Germany.
  • Foraita R; Department of Biometry and Data Management, Leibniz Institute for Prevention Research and Epidemiology - BIPS, Bremen, Germany.
  • Nelis M; Estonian Genome Center, University of Tartu, Tartu, Estonia.
  • Lagiou P; Department of Hygiene, Epidemiology and Medical Statistics, University of Athens Medical School, Athens, Greece.
  • Lagiou A; Faculty of Health Professions, Athens Technological Educational Institute, Athens, Greece.
  • Bouchardy C; Geneva Cancer Registry, Institute of Social and Preventive Medicine, Geneva Cancer Registry, IMSP, University of Geneva, Geneva, Switzerland.
  • Slamova A; Institute of Hygiene and Epidemiology, First Faculty of Medicine, Charles University of Prague, Prague, Czech Republic.
  • Schejbalova M; Institute of Hygiene and Epidemiology, First Faculty of Medicine, Charles University of Prague, Prague, Czech Republic.
  • Merletti F; Department of Medical Sciences, Cancer Epidemiology Unit, CeRMS and CPO Piemonte University of Turin, Turin, Italy.
  • Richiardi L; Department of Medical Sciences, Cancer Epidemiology Unit, CeRMS and CPO Piemonte University of Turin, Turin, Italy.
  • Kjaerheim K; Cancer Registry of Norway, Oslo, Norway.
  • Agudo A; Catalan Institute of Oncology (ICO), CIBERESP, IDIBELL, L'Hospitalet de Llobregat, Barcelona, Spain; Catalan Institute of Oncology (ICO), IDIBELL, L'Hospitalet de Llobregat, Barcelona, Spain.
  • Castellsague X; Catalan Institute of Oncology (ICO), CIBERESP, IDIBELL, L'Hospitalet de Llobregat, Barcelona, Spain.
  • Macfarlane TV; School of Medicine and Dentistry, University of Aberdeen, Aberdeen, United Kingdom.
  • Macfarlane GJ; School of Medicine and Dentistry, University of Aberdeen, Aberdeen, United Kingdom.
  • Lee YC; Department of Family and Preventive Medicine, Division of Public Health, School of Medicine, University of Utah, Utah, USA.
  • Talamini R; Aviano Cancer Centre, Aviano, Italy.
  • Barzan L; General Hospital of Pordenone, Pordenone, Italy.
  • Canova C; National Heart and Lung Institute, Imperial College London, London, United Kingdom; Laboratory of Public Health and Population Studies, Department of Molecular Medicine, University of Padova, Padova, Italy.
  • Simonato L; Laboratory of Public Health and Population Studies, Department of Molecular Medicine, University of Padova, Padova, Italy.
  • Thomson P; School of Dental Sciences, University of Newcastle, Newcastle, United Kingdom.
  • McKinney PA; Centre for Epidemiology and Biostatistics, University of Leeds, Leeds, United Kingdom.
  • McMahon AD; Glasgow Dental School, College of Medical, Veterinary and Life Sciences, College of Medicine, University of Glasgow, Glasgow, United Kingdom.
  • Znaor A; Croatian National Cancer Registry, Zagreb, Croatia.
  • Healy CM; Trinity College School of Dental Science, Dublin, Ireland.
  • McCartan BE; Trinity College School of Dental Science, Dublin, Ireland; School of Medicine, Royal College of Surgeons in Ireland, Dublin, Ireland.
  • Metspalu A; Institute of Molecular and Cell Biology, University of Tartu, Tartu, Estonia; Estonian Genome Center, University of Tartu, Tartu, Estonia; Center of Translational Genomics, University of Tartu, Tartu, Estonia.
  • Marron M; International Agency for Research on Cancer (IARC), Lyon, France; Institute of Medical Biostatistics, Epidemiology and Informatics (IMBEI), University of Mainz, Mainz, Germany.
  • Hashibe M; Department of Family and Preventive Medicine, Division of Public Health, School of Medicine, University of Utah, Utah, USA; Huntsman Cancer Institute, Salt Lake City, Utah, USA.
  • Conway DI; Glasgow Dental School, College of Medical, Veterinary and Life Sciences, College of Medicine, University of Glasgow, Glasgow, United Kingdom.
  • Brennan P; International Agency for Research on Cancer (IARC), Lyon, France. Electronic address: brennan@iarc.fr.
Oral Oncol ; 50(6): 616-25, 2014 Jun.
Article en En | MEDLINE | ID: mdl-24680035
ABSTRACT

OBJECTIVE:

We aimed to assess the association of oral health (OH), dental care (DC) and mouthwash with upper-aerodigestive tract (UADT) cancer risk, and to examine the extent that enzymes involved in the metabolism of alcohol modify the effect of mouthwash. MATERIALS AND

METHODS:

The study included 1963 patients with incident cancer of the oral cavity, oropharynx, hypopharynx, larynx or esophagus and 1993 controls. Subjects were interviewed about their oral health and dental care behaviors (which were converted to scores of OH and DC respectively), as well as smoking, alcohol drinking, diet, occupations, medical conditions and socio-economic status. Blood samples were taken for genetic analyses. Mouthwash use was analyzed in relation to the presence of polymorphisms of alcohol-metabolizing genes known to be associated with UADT. Adjusted odds ratios (ORs) and 95%-confidence intervals [CI] were estimated with multiple logistic regression models adjusting for multiple confounders.

RESULTS:

Fully adjusted ORs of low versus high scores of DC and OH were 2.36[CI=1.51-3.67] and 2.22[CI=1.45-3.41], respectively, for all UADT sites combined. The OR for frequent use of mouthwash use (3 or more times/day) was 3.23[CI=1.68-6.19]. The OR for the rare variant ADH7 (coding for fast ethanol metabolism) was lower in mouthwash-users (OR=0.53[CI=0.35-0.81]) as compared to never-users (OR=0.97[CI=0.73-1.29]) indicating effect modification (pheterogeneity=0.065) while no relevant differences were observed between users and non-users for the variant alleles of ADH1B, ADH1C or ALDH2.

CONCLUSIONS:

Poor OH and DC seem to be independent risk factors for UADT because corresponding risk estimates remain substantially elevated after detailed adjustment for multiple confounders. Whether mouthwash use may entail some risk through the alcohol content in most formulations on the market remains to be fully clarified.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Higiene Bucal / Neoplasias Esofágicas / Salud Bucal / Neoplasias de Cabeza y Cuello / Antisépticos Bucales Tipo de estudio: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans País/Región como asunto: Europa Idioma: En Revista: Oral Oncol Asunto de la revista: NEOPLASIAS Año: 2014 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Higiene Bucal / Neoplasias Esofágicas / Salud Bucal / Neoplasias de Cabeza y Cuello / Antisépticos Bucales Tipo de estudio: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans País/Región como asunto: Europa Idioma: En Revista: Oral Oncol Asunto de la revista: NEOPLASIAS Año: 2014 Tipo del documento: Article
...